Leerink and LifeSci Capital acted as joint book running managers for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADAG:
- Adagene enters pact with Incyte for combination of muzastotug, INCA33890
- Adagene announces results from the latest data cut of muzastotug study
- Adagene Posts Strong Muzastotug Data and Incyte Collaboration in MSS Colorectal Cancer
- Adagene Prices US$70 Million ADS Offering to Bolster Cancer Immunotherapy Pipeline
- Adagene Posts 2025 Results as Muzastotug Data, Partnerships Extend Cash Runway to 2028